News & Updates

Shingles vaccine may prevent strokes

18 Mar 2020 by

Vaccination against herpes zoster (shingles) with the Zoster Vaccine Live (ZVL) vaccine may reduce the risk of stroke in older adults, according to a study presented at the recent ISC 2020 conference.

Shingles vaccine may prevent strokes

18 Mar 2020

Liraglutide suitable for T2D patients regardless of heart failure history

18 Mar 2020

The glucagon-like peptide-1 receptor agonist liraglutide has been shown to be safe in patients with type 2 diabetes (T2D) with or without a history of New York Heart Association (NYHA) functional class I to III heart failure (HF), according to a study.

Liraglutide suitable for T2D patients regardless of heart failure history

18 Mar 2020

Standard ART plus maraviroc does not improve outcomes in treatment-naïve HIV patients

18 Mar 2020

Adding maraviroc to standard combined antiretroviral therapy (c-ART), which consists of three or more ART drugs, does not result in better clinical outcomes among patients initiating treatment for advanced HIV infection, reveals a study.

Standard ART plus maraviroc does not improve outcomes in treatment-naïve HIV patients

18 Mar 2020

Nemolizumab alleviates skin symptoms in prurigo nodularis

18 Mar 2020 by

Use of the interleukin-31 receptor A monoclonal antibody nemolizumab significantly reduced the severity of pruritus in patients with moderate-to-severe prurigo nodularis, a phase II trial has shown.

Nemolizumab alleviates skin symptoms in prurigo nodularis

18 Mar 2020

tPA before mechanical thrombectomy: To SKIP or not?

18 Mar 2020 by

Skipping intravenous (IV) tissue plasminogen activator (tPA) before mechanical thrombectomy (MT) may have similarly favourable outcomes to using tPA pre-MT in patients with acute stroke, according to the SKIP* study presented at ISC 2020.

tPA before mechanical thrombectomy: To SKIP or not?

18 Mar 2020

Wearable sensor patch reliably predicts worsening heart failure

17 Mar 2020 by

A novel, wearable heart failure (HF) patch accurately predicted worsening HF and impending rehospitalization days before the event actually happened in adults who were recently discharged from hospitalization for HF (HHF), according to the LINK-HF* study.

Wearable sensor patch reliably predicts worsening heart failure

17 Mar 2020

Ultra-low dose estriol vaginal gel effective against vulvovaginal atrophy

17 Mar 2020

Treatment with the ultra-low dose 0.005% estriol vaginal gel yields improvements in symptoms and signs of vulvovaginal atrophy, with minimal oscillations in hormonal levels, according to the results of a phase II trial.

Ultra-low dose estriol vaginal gel effective against vulvovaginal atrophy

17 Mar 2020

Apixaban better than rivaroxaban in routine care of patients with atrial fibrillation

17 Mar 2020

Incidence of ischaemic stroke or systemic embolism is lower in adults with atrial fibrillation treated with apixaban than those prescribed rivaroxaban, results of a recent study have shown.

Apixaban better than rivaroxaban in routine care of patients with atrial fibrillation

17 Mar 2020

SPIRIT-P1: Ixekizumab suitable for long-term treatment of psoriatic arthritis

17 Mar 2020 by

Ixekizumab induces early and durable improvements in psoriatic arthritis (PsA) patients naïve to biological disease-modifying antirheumatic drugs (bDMARDs), with response occurring as early as week 1 and persisting throughout 3 years of treatment without incremental safety risks, according to the results of the phase III SPIRIT-P1* trial.

SPIRIT-P1: Ixekizumab suitable for long-term treatment of psoriatic arthritis

17 Mar 2020

Original New Drug Application Approvals by US FDA (01 - 15 March 2020)

17 Mar 2020

New drug applications approved by US FDA as of 01 - 15 March 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 March 2020)

17 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

Shingles vaccine may prevent strokes

Shingles vaccine may prevent strokes

Liraglutide suitable for T2D patients regardless of heart failure history

Liraglutide suitable for T2D patients regardless of heart failure history

Standard ART plus maraviroc does not improve outcomes in treatment-naïve HIV patients

Standard ART plus maraviroc does not improve outcomes in treatment-naïve HIV patients

Nemolizumab alleviates skin symptoms in prurigo nodularis

Nemolizumab alleviates skin symptoms in prurigo nodularis

tPA before mechanical thrombectomy: To SKIP or not?

tPA before mechanical thrombectomy: To SKIP or not?

Wearable sensor patch reliably predicts worsening heart failure

Wearable sensor patch reliably predicts worsening heart failure

Ultra-low dose estriol vaginal gel effective against vulvovaginal atrophy

Ultra-low dose estriol vaginal gel effective against vulvovaginal atrophy

Apixaban better than rivaroxaban in routine care of patients with atrial fibrillation

Apixaban better than rivaroxaban in routine care of patients with atrial fibrillation

SPIRIT-P1: Ixekizumab suitable for long-term treatment of psoriatic arthritis

SPIRIT-P1: Ixekizumab suitable for long-term treatment of psoriatic arthritis

Original New Drug Application Approvals by US FDA (01 - 15 March 2020)

Original New Drug Application Approvals by US FDA (01 - 15 March 2020)